SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (1723)12/7/2006 6:24:20 PM
From: Mike McFarland  Read Replies (1) | Respond to of 3722
 
If it isn't too much trouble do the charts
for any of these symbols look especially
weak of late?

arna crxl exel kerx maxy medx mygn rnvo.L

I know that is a lot of symbols to throw out
there, and I am not looking for a detailed
analysis. If you're willing to take it on,
great--but I won't have my feelings hurt if
it's too much work. No rush either--these
are members of a portfolio that's had no
turnover for several months. I might cast
one out of the portfolio if the chart obviously
stinks.



To: Jibacoa who wrote (1723)12/7/2006 7:07:59 PM
From: Steve Lokness  Read Replies (1) | Respond to of 3722
 
Bernard - Thanks for the explanation.

What I like about P&F 3 box charting is that it is suppose to shift through the noise and when it signals, the signals are for real change. In the case of SGEN, it is the first buy signal from the stock since 2004 I believe. Looking at the longer term chart you provided one would have done well to stay away from the stock since its last sell single a couple of years ago. Doesn't mean you couldn't have made money trading - but the trend has been down. If the P&F charting is right - it has now entered a bull phase.

What I am really interested in is your opinion as to how well the technical charting applies to biotechs. Perhaps SGEN was not the best example for me to use because of the insider buying.

Good Investing!
steve